https://www.biogen.co.nz/content/corporate/apac/new-zealand/en-nz/disease-areas/spinal-muscular-atrophy.html
Spinal Muscular Atrophy, an inherited disease that can have a devastating effect on voluntary muscle movement, affects approximately one in every 10,000 births...
spinal muscular atrophy
https://www.biogen.com.au/disease-areas/spinal-muscular-atrophy.html
Spinal Muscular Atrophy, an inherited disease that can have a devastating effect on voluntary muscle movement, affects approximately one in every 10,000 births...
spinal muscular atrophy
https://www.irishexaminer.com/lifestyle/people/arid-41769962.html
Nelson said she had made her children’s diagnosis public as she wanted to raise awareness of the condition.
jesy nelsonrevealstwinsunlikelywalk
https://clarivate.com/life-sciences-healthcare/blog/understanding-the-epidemiology-of-sma/
Dec 19, 2025 - Highlights and key takeaways of a Clarivate epidemiological study into how global SMA prevalence is shaped by genetics, healthcare and socioeconomic factors...
spinal muscular atrophyunderstandingepidemiology
https://www.biogen.ca/en-ca/disease-areas/spinal-muscular-atrophy.html
SMA, an inherited disease that can have a devastating effect on voluntary muscle movement, affects approximately one in every 10,000 births worldwide. Before...
spinal muscular atrophy
https://www.biogen.com/disease-areas/spinal-muscular-atrophy.html
SMA, an inherited disease that can have a devastating effect on voluntary muscle movement, affects approximately one in every 10,000 births worldwide. Before...
spinal muscular atrophybiogen
https://celebrity.nine.com.au/latest/jesy-nelson-twin-daughters-diagnosis-rare-genetic-condition-sma-type-1/285a65e8-dd0d-4e7b-aad6-100fb3287408
Jan 4, 2026 - Jesy Nelson has revealed her baby daughters have been diagnosed with a rare genetic condition which means t...
jesy nelsonrevealstwindaughtersdiagnosed
https://endpoints.news/fda-approves-novartis-itvisma-for-older-patients-with-spinal-muscular-atrophy/
Nov 25, 2025 - FDA approves Novartis' Itvisma, a new SMA gene therapy for patients 2+ years old at $2.59M, expanding treatment options beyond Zolgensma
fdaolderpatientsspinalmuscular
https://www.biogen-sa.com/disease-areas/spinal-muscular-atrophy.html
SMA, an inherited disease that can have a devastating effect on voluntary muscle movement, affects approximately one in every 10,000 births worldwide. Before...
spinal muscular atrophy